Latest Breaking News On - Discov today dis - Page 3 : comparemela.com

On World Sleep Day Idorsia highlights the publication of a global study on the economic and societal impact of chronic insomnia disorder

On World Sleep Day Idorsia highlights the publication of a global study on the economic and societal impact of chronic insomnia disorder
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSwitzerland generalUnited kingdomMarco hafnermarco hafnerJean paul clozelYerushalmie troxelSanta monicaAndrewc weissseniorMarco hafnerAmerican psychiatric associationWorld sleep societyInternational classification of sleep disordersUniversity of freiburgAmerican academy of sleep medicineInternational studytheUniversity of zurich

GNW-Adhoc: On World Sleep Day Idorsia highlights the publication of a global study on the economic and societal impact of chronic insomnia disorder

^ Chronic insomnia disorder (CID) is a persistent medical condition that prevents sufferers from getting restorative sleep(1-3); research on wider societal and indirect economic costs associated with CID have been limited to date(1) New report indicates annual lost productivity costs of $417 .

United statesSwitzerland generalUnited kingdomAndrewc weissJean paul clozelYerushalmie troxelMarco hafnerAmerican psychiatric associationInternational classification of sleep disordersWorld sleep societyHead of investor relations corporate communicationsUniversity of freiburgAmerican academy of sleep medicineUniversity of zurichIdorsia ltdOrganization for economic

BÖRSE ONLINE – Seit 1987, Deutschlands erstes Börsenmagazin

TODO

United statesSwitzerland generalUnited kingdomAndrewc weissMarco hafnerJean paul clozelYerushalmie troxelSanta monicaAmerican psychiatric associationWorld sleep society dayWorld sleep societyInternational classification of sleep disordersUniversity of freiburgIdorsia ltdAmerican academy of sleep medicineUniversity of zurich

Idorsia Pharmaceuticals UK Ltd : New research reveals chronic insomnia disorder costs UK economy up to £34billion per year

First of its kind research indicates that if chronic insomnia disorder (CID) was treated effectively and comprehensively across the working age population, it could increase the GDP in the UK

City ofUnited kingdomUnited statesDennis riedlYerushalmie troxelSanta monicaRobert mooreMarco hafnerKevin bamptonIdorsia ltdAmerican psychiatric associationInternational classification of sleep disordersOrganisation for economicBritish occupational hygiene societyInstitute for employment researchUniversity of freiburg

Idorsia Pharmaceuticals Ltd: Swissmedic approves QUVIVIQ (daridorexant) - a first-in-class treatment for chronic insomnia disorder to improve both nighttime symptoms and daytime functioning

QUVIVIQ is indicated for the treatment of adult patients with insomnia characterized by symptoms present for at least three months and considerable impact on daytime functioningQUVIVIQ, Switzerland's first

United statesUnited kingdomSwitzerland generalGreat britainAndrewc weissJean paul clozelAlice huismanJ clin pharmacolIdorsia ltdAmerican psychiatric associationHead of investor relations corporate communicationsEuropean commission decision reliance procedureEuropean commissionDrug administrationSwiss exchangeRegulatory agency